Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Genomic Health Inc. Stories

2011-08-03 15:00:00

REDWOOD CITY, Calif., Aug. 3, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2011. Total revenue increased to $50.8 million in the second quarter of 2011, compared with $43.4 million in the second quarter of 2010. Product revenue was $50.5 million in the second quarter of 2011, an increase of 19 percent, compared with $42.5 million in the second quarter of 2010. Net income was $2.3...

2011-07-27 07:00:00

REDWOOD CITY, Calif., July 27, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, August 3 at 4:30 p.m. Eastern Time to discuss its second quarter 2011 financial results. The call and webcast will follow the release of the second quarter financial results after market close. Conference Call Details To access the live conference call on August 3 at 4:30 p.m. Eastern Time via phone, please dial...

2011-06-04 12:00:00

CHICAGO, June 4, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of ten studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including a second large validation study confirming the performance of the Oncotype DX® colon cancer Recurrence Score® (RS) as an independent predictor of recurrence risk in stage II colon cancer. The company also will present positive findings from a...

2011-05-27 07:00:00

REDWOOD CITY, Calif., May 27, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in June: Brad Cole, Genomic Health's Chief Operating Officer, will present at the Jefferies 2011 Global Healthcare Conference on Monday, June 6 at 3:30 p.m. ET in New York City; and Kim Popovits, Genomic Health's President and Chief Executive Officer, and Dean Schorno, Genomic Health's Chief Financial Officer,...

2011-05-24 08:00:00

REDWOOD CITY, Calif., May 24, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from a study of Oncotype DX® in patients with DCIS (ductal carcinoma in situ of the breast) conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative group supported by the National Cancer Institute. The ECOG 5194 validation study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS...

2011-05-18 17:00:00

REDWOOD CITY, Calif., May 18, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from ten separate studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7, 2011 at McCormick Place in Chicago. The company markets the widely-adopted Oncotype DX® breast cancer test, which is clinically validated to predict chemotherapy benefit as well as the likelihood of recurrence in...

2011-05-03 15:08:00

REDWOOD CITY, Calif., May 3, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2011. Total revenue increased to $49.8 million in the first quarter of 2011, compared with $41.2 million in the first quarter of 2010. Product revenue was $49.5 million in the first quarter of 2011, an increase of 23 percent, compared with $40.3 million in the first quarter of 2010. Net loss was $0.3 million in...

2011-04-26 07:00:00

REDWOOD CITY, Calif., April 26, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the launch of RxPONDER S1007 (Rx for Positive Node, Endocrine Responsive Breast Cancer), a clinical trial being led by SWOG, one of the largest National Cancer Institute (NCI) supported cancer cooperative groups. The trial is designed to determine the effect of chemotherapy in breast cancer patients with one to three positive nodes who have a Recurrence Score® (RS)...

2011-04-25 07:00:00

REDWOOD CITY, Calif., April 25, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 3 at 4:30 p.m. Eastern Time to discuss its first quarter 2011 financial results. The call and webcast will follow the release of the first quarter financial results after market close. Conference Call Details To access the live conference call on May 3 at 4:30 p.m. Eastern Time via phone, please dial (877)...

2011-03-17 08:30:00

REDWOOD CITY, Calif. and ST. GALLEN, Switzerland, March 17, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from nine studies utilizing the Oncotype DX® test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St. Gallen, Switzerland. The studies included region-specific decision impact data that demonstrated the knowledge of a patient's Recurrence Score® (RS)...